Submission Details
| 510(k) Number | K850933 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 07, 1985 |
| Decision Date | June 25, 1985 |
| Days to Decision | 110 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | — |
K850933 is an FDA 510(k) clearance for the URIC ACID, a Acid, Uric, Phosphotungstate Reduction (Class I — General Controls, product code CDH), submitted by Dilab, Inc. (Miami, US). The FDA issued a Cleared decision on June 25, 1985, 110 days after receiving the submission on March 7, 1985. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1775.
| 510(k) Number | K850933 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 07, 1985 |
| Decision Date | June 25, 1985 |
| Days to Decision | 110 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | — |
| Product Code | CDH — Acid, Uric, Phosphotungstate Reduction |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 862.1775 |